ANYA BIOPHARM INC.
奧孟亞股份有限公司
Leave your email for change alerts (optional)
2016Founded
NT$491MPaid-in capital
0Plants
1Patents
< NT$20MRevenue band
- Unified Business No.
- 66262721
- TWSE / TPEx sector
- Biotech & medical
- Listing
- Emerging stock (TPEx) (359) 7776
- Founded
- 2016-11-01
- Paid-in capital
- NT$ 491,015,200
- Phone
- 02-26558988
- Website
- http://anyabiopharm.com/tw/
- Exporter
- Yes — registered with the Trade Administration
- Annual revenue band
- < NT$20M
- Ownership
- Individually held
- Representative tenure
- In office since 2025-03 (1 yrs); last handover 2025-03
- Growth & profitability
- Revenue 2026-09 YoY 0.0%, year-to-date -74.6%
Gross margin 90.1%, operating margin -8508.4%, net margin -7336.7% (2026-Q2 YTD)
Patents 1
- 2023 Oral formulation of PTH analog and treatment thereof
Similar companies 10
- BRIM BIOTECHNOLOGY INC. Listed (TWSE) < NT$20M
Shared: Other professional, scientific & technical services n.e.c., Natural & engineering science R&D services, Western pharmaceutical wholesale - LIN BIOSCIENCE, INC. Emerging stock (TPEx) < NT$20M estimated
Shared: Natural & engineering science R&D services, Western pharmaceutical wholesale - TAIWANJ PHARMACEUTICALS, CO., LTD. Emerging stock (TPEx) NT$20–100M estimated
Shared: Other professional, scientific & technical services n.e.c., Natural & engineering science R&D services, Western pharmaceutical wholesale - ORIGINAL BIOMEDICALS CO., LTD. Emerging stock (TPEx) NT$100–500M estimated
Shared: Other professional, scientific & technical services n.e.c., Natural & engineering science R&D services - DV Biomed Co., Ltd. Emerging stock (TPEx) NT$100–500M estimated
Shared: Other professional, scientific & technical services n.e.c., Marketing management consulting - TRIPARTITE THERAPEUTICS INC. Emerging stock (TPEx) NT$0.5–1B estimated
Shared: Natural & engineering science R&D services - FORMOSA PHARMACEUTICALS , INC. Listed (TWSE) NT$20–100M
Shared: Other professional, scientific & technical services n.e.c., Western pharmaceutical wholesale - UWELL BIOPHARMA INC. Emerging stock (TPEx) NT$0.5–1B estimated
Shared: Other professional, scientific & technical services n.e.c., Natural & engineering science R&D services - DIAMOND BIOFUND INC. Listed (TWSE) NT$1–5B
Shared: Other professional, scientific & technical services n.e.c., Natural & engineering science R&D services - PHARMOSA BIOPHARM INC. Listed (TPEx) NT$0.5–1B estimated
Shared: Other professional, scientific & technical services n.e.c., Natural & engineering science R&D services